Increases the concentration in the blood of digoxin, theophylline, prazosin, cyclosporine, carbamazepine, muscle relaxants, quinidine,valproic acid due to suppression of metabolism involving cytochrome P450.
Cimetidine increases bioavailability of verapamil by almost 40 % (due to a decrease in metabolism in the liver), in connection with which, it may be necessary to reduce the dose of the latter.
Calcium preparations reduce the effectiveness of verapamil.
Rifampicin, barbiturates, nicotine, accelerating the metabolism in the liver, lead to a decrease in the concentration of verapamil in the blood, reduce the severity of antianginal, hypotensive and antiarrhythmic action.
With simultaneous use with inhalation anesthetics, the risk of bradycardia, atrioventricular blockade, and heart failure increases. Procainamide, quinidine and other drugs that cause lengthening of the interval QT, increase the risk of significant lengthening of the latter.
Combination with beta-blockers can lead to an increase in the negative inotropic effect, an increased risk of developing atrioventricular conduction disorders, bradycardia (the administration of verapamil and beta-blockers should be performed at intervals of several hours).
Prazosin and other alpha-adrenoblockers increase the hypotensive effect. Nonsteroidal anti-inflammatory drugs reduce the hypotensive effect due to suppression of prostaglandin synthesis, delay of sodium ions and fluid in the body.
Increases the concentration of cardiac glycosides (requires careful monitoring and reduction of the dose of cardiac glycosides).
Sympathomimetics reduce the hypotensive effect of verapamil.
Dysopyramide and flecainide should not be administered within 48 hours before and 24 hours after the use of verapamil (summation of a negative inotropic effect, up to a fatal outcome).
Estrogens reduce the hypotensive effect due to fluid retention in the body. It is possible to increase concentrations in the blood plasma of drugs characterized by a high degree of binding to proteins (including coumarin and indanedione derivatives, nonsteroidal anti-inflammatory drugs, quinine, salicylates, sulfinpyrazone).
Drugs that reduce blood pressure, increase the hypotensive effect of verapamil.
Increases the risk of neurotoxic effect of lithium drugs.
Strengthens the activity of peripheral muscle relaxants (may require a change in the dosage regimen).